Virtual reality isn't just for gaming. Researchers in the Netherlands pooled 16 studies covering 817 people to ask a straightforward question: can facing your fears inside a headset work as well as facing them in real life?
Exposure therapy is a core part of treatment for OCD, anxiety and PTSD. It means gradually approaching what you've been avoiding, so your brain gets the chance to learn that the danger isn't what it feels like. Virtual reality lets that happen in a setting a therapist can control and repeat.
The findings were encouraging. People who did VR-based exposure improved noticeably more than those still waiting for treatment. Compared head-to-head with standard face-to-face therapy, VR did about as well, with no meaningful difference between them. Just as many people stayed the course, too, as dropout rates were similar.
Worth knowing: this review looked at more severe anxiety disorders, OCD and PTSD together, and the authors were careful to note that the quality of some included studies was hard to judge. They'd like stronger trials before anyone draws firm conclusions.
Still, it suggests VR could become a real option, particularly when arranging real-life exposure is difficult. If OCD or anxiety is making your world smaller than you'd like, please reach out. Effective help does exist.
Exposure therapy, briefly
A lot of effective treatment for OCD, anxiety disorders, and PTSD relies on exposure: deliberately and gradually confronting the thing you fear or avoid, under safe conditions, so your brain updates its predictions about danger. This is usually done as part of cognitive behavioral therapy (CBT), and for OCD specifically it's often called exposure and response prevention (ERP) — you face the trigger and resist the compulsion. Virtual reality exposure-based CBT (VRE-CBT) uses a headset to simulate the feared situation instead of, or alongside, doing it in real life.
What this study did
Loenen et al conducted a meta-analysis, a statistical method that combines results from multiple separate studies to get a more precise, pooled estimate than any single study can give. They searched for trials published up to August 2020 and included 16 trials covering 817 participants. Importantly, they deliberately excluded studies on specific phobias (like fear of spiders) and mild, subclinical anxiety, focusing instead on more severe, disabling anxiety disorders, OCD, and PTSD — conditions where it's less obvious that a headset could substitute for real life.
They compared VRE-CBT against two things: a waitlist (people not yet receiving treatment) and standard face-to-face CBT. To measure how big the differences were, they calculated Hedges g, a type of effect size that expresses the gap between two groups in standardized units, making it possible to compare across studies that used different symptom scales. As a rough guide, effect sizes around 0.2 are considered small, 0.5 medium, and 0.8 large. They used a random effects model, a statistical approach that assumes the true effect can genuinely vary somewhat between studies rather than being identical everywhere, and reported 95% confidence intervals (CIs) — a range that, loosely, indicates how precise each estimate is.
What it found
Compared with waitlist, VRE-CBT produced a medium, statistically significant improvement (Hedges g = -0.49, 95% CI -0.82 to -0.16, p = .003) — meaning people doing VR-based exposure improved clearly more than those receiving no treatment yet.
Compared directly with standard CBT, the difference was small and not statistically significant (Hedges g = 0.083, 95% CI -0.13 to 0.30, p = .45), slightly favoring regular CBT but not meaningfully so. Dropout rates were also compared using an odds ratio (a ratio comparing the odds of an event, here quitting treatment, between two groups); there was no significant difference between VRE-CBT and CBT (odds ratio 0.79, 95% CI 0.49-1.27, p = .32). The authors also checked for small-study effects and publication bias — patterns that can occur when small or negative studies go unpublished or distort results — and found no evidence of either here.
Why it matters, and its limits
For more severe anxiety disorders, OCD, and PTSD combined, this pooled evidence suggests VRE-CBT beats no treatment and holds its own against standard CBT, with comparable dropout. That's a meaningful finding for a technology often dismissed as a novelty. However, the authors flagged that many included trials had unclear or missing information about how they randomized participants and concealed allocation, both of which affect how much we can trust individual results. They call for higher-quality randomized controlled trials before drawing firm conclusions.
If anxiety, OCD, or PTSD symptoms are shrinking your world, know that effective, evidence-based treatments exist — please consider reaching out to a qualified professional.